Prescription Drugs Involved in Personal Injury Lawsuits

Zantac Lawsuits – Stomach and Bladder Cancer

Zantac Lawsuits – Stomach and Bladder Cancer

Zantac manufacturer Sanofi faces numerous lawsuits alleging that the popular heartburn medication may cause bladder and stomach cancer. In September 2019, the FDA issued a consumer advisory to alert the public of the potential dangers of Zantac and similar medications. Following the FDA's announcement, major drugstore chains--including CVS and Walgreens---pulled Zantac from their shelves to protect consumers. In April 2020, the FDA released a formal recall request, calling for all manufacturers of ranitidine drugs, such as Zantac, to pull their products from shelves immediately over concerns of exposure to potential carcinogens. If you developed bladder, stomach, kidney, or colon cancer after taking Zantac, call our experienced defective drug attorneys to explore the next steps for your Zantac lawsuit. What is Zantac? Zantac is a brand name heartburn medication sold both over-the-counter and by prescription. Zantac's active ingredient is ranitidine, a histimine blocker that targets the stomach to decrease painful acid. Ranitidine is a common ingredient in several other brand-name and generic heartburn relief drugs. Unfortunately, ranitidine is also linked to a substance called N-nitrosodimethylamine (NDMA). The CDC describes NDMA as a "research chemical" that was once used in rocket fuel, but was discontinued for such uses when high levels of...
Read More

Low Testosterone: FDA Panel Backs Limits on Drugs

The New York Times reports that a panel of twenty medical experts voted for the Food and Drug Administration (FDA) to impose new limitations on the testosterone drug industry. The panel recommended that the agency tighten the labeling of these drugs so they are not prescribed to men who are only experiencing the effects of getting older, such as decreased energy and libido. While the FDA is not required to do what the panel tells it to do, the agency usually follows the advice of such expert panels. Meanwhile there is increasing medical evidence that testosterone has serious side effects and can, in certain patients, cause serious injury including, potentially melanoma (serious skin cancer). JAMA Intern Med. 2014. For questions about product liability for Low T (testosterone) drugs Click here to contact us for a confidential case review.
Read More

Xarelto Lawsuits May Move to MDL in S.D. Ill.

On December 2, 2014 the Judicial Panel on Multidistrict Litigation (JPML) will hear oral argument to transfer the currently pending Xarelto cases against Bayer Pharmaceuticals and Janssen Pharmaceuticals to the U.S. District Court for the Southern District of Illinois. The current suits allege the manufacturers failed to warn the public about the dangers of Xarelto. Xarelto® may increase the risk for life-threatening side effects, including uncontrollable bleeding events and blood clots.Pennsylvania researchers recently published a study that emphasizes the dangers of excessive bleeding associated with anticoagulants. The search for a cure for Xarelto brain bleeds and bleeding events caused by other similar-acting blood thinners has kept researchers busy since Pradaxa entered the market in late 2010. The makers of Xarelto and Pradaxa are now facing lawsuits across the country based on excessive bleeding injuries.There are at least 21 Xarelto bleeding lawsuits pending in 10 different federal district courts across the country. Each of these Xarelto lawsuits alleges that the anticoagulant caused users to develop severe, and sometimes fatal, internal bleeding injuries. In general, Xarelto lawsuits are filed individually by each plaintiff and are not class actions. If you or a family member have experienced bleeding or blood clots from Xarelto,...
Read More

Tennessee Personal Injury Lawyer: Cook IVC Filter Litigation

On Oct. 24, 2014 the U.S. Judicial Panel on Multidistrict Litigation (JPML) transferred all pending federally filed Cook inferior vena cava (IVC) filter lawsuits to U.S. District Judge Richard L. Young in the Southern District of Indiana, for coordinated pretrial proceedings. IN RE: COOK MEDICAL, INC., IVC FILTERS MARKETING, SALES PRACTICES AND PRODUCTS LIABILITY LITIGATION MDL No. 2570. This order by the JPML establishes a nationwide federal Multidistrict Litigation (MDL) in one courthouse. This MDL will include all product liability and personal injury lawsuits involving side effect complications with Cook IVC filters. If you or a family member has experienced injuries from Cook IVC or other inferior vena cava filters, please call us (Tennessee Cook IVC Lawyer) at 1-800-394-2119 or click here to contact us for a confidential case review. What are Cook IVC Filters? Cook IVC Filters are small metallic spider-like devices implanted by doctors to prevent blood clots from traveling from the leg (known as a deep vein thrombosis) to the lungs and causing a pulmonary embolism (blood clot in the lung). There are two main models, the Cook Celect and Gunther Tulip filters. The devices are commonly used when anticoagulant therapy is contraindicated because of bleeding risks...
Read More

Tennessee Testosterone Treatment Lawsuits

Our firm is evaluating testosterone lawsuits on behalf of men who allegedly suffered heart attacks, strokes, deep vein thrombosis, pulmonary embolism and other serious cardiovascular problems as a result of certain hormone replacement therapies. More than 220 testosterone lawsuits have now been filed in the U.S. District Court, Northern District of Illinois, where cases involving a number of prescription hormone therapies have been centralized in a federal multi district litigation. A Case List updated on October 15th shows 223 claims now pending in the Northern District of Illinois on behalf of individuals who allegedly suffered strokes, heart attacks, deep vein thrombosis, pulmonary embolism and other serious cardiovascular problems as a result of AndroGel, Testim, Axiron and other prescription therapies. According to claims, the makers of these products failed to adequately warn about their alleged side effects, which may be life-threatening. (In re: Testosterone Replacement Therapy Product Liability Litigation - MDL No. 2545) According to court records, testosterone lawsuits now filed in the Northern District of Illinois similarly accuse the drug manufacturers of concealing vital safety information about their products from the public. Plaintiffs further allege that the makers of AndroGel and other medications marketed them for age-related “Low T,” a...
Read More

Zofran Lawsuits – Pregnancy Claims & Birth Defect Litigation

Doctors prescribe Zofran (ondansetron) to pregnant women as a treatment for nausea and vomiting during pregnancy. Unfortunately, studies link the medication to birth defects, and families are taking drugmaker GlaxoSmithKline to court, saying it marketed the drug to pregnant women without FDA approval. Click here for a free & confidential case review Unapproved Zofran Use The U.S. Food and Drug Administration approved Zofran to help cancer patients with nausea after treatments or after surgery. It helped people who vomited as a side effect from chemotherapy or who grew sick after taking post-op meds to help with pain or other complications. But drugmaker GlaxoSmithKline soon found other patients to take the drug – pregnant women suffering from morning sickness. There was just one problem. The FDA never approved Zofran for use by pregnant women. In 2012, Glaxo pleaded guilty to federal charges of fraud and illegal promotion of several drugs, including Zofran, and paid $3 billion as part of the legal settlement. Now the company is going back to court to defend more specific allegations about Zofran (ondansetron). Why Are Former Zofran Users Filing Lawsuits? Court documents show Glaxo knew as early as 1992 that Zofran presented "unreasonable risk of harm"...
Read More
fda warning cardiac patients fungal infections

fda warning cardiac patients fungal infections

FDA Warns Cardiac Patients May Be at Risk for NECC Cardioplegia Solutions Update (October 16): On Tuesday the FDA revised its initial report and said that only one transplant patient who had received the NECC cardioplegia solution had developed fungal meningitis.The FDA said on Monday that it had identified two transplant patients with Aspergillus fumigatus infection who received cardioplegia solution during surgery. The solution was manufactured by the New England Compounding Center (NECC), which has been at the center of a broad investigation after the death of several patients from fungal meningitis due to contaminated vials of methylprednisolone acetate injection.The FDA said is had also identified a patient who may have developed meningitis from an epidural injection of another injectable steroid made by NECC, triamcinolone acetonide. The FDA said “there may be other explanations” for the infections in the transplant patients and that it has not confirmed that the three cases were caused by NECC products.Out of “an abundance of caution” the FDA recommends that patients who received any injectable drugs manufactured by NECC “should be alerted to the potential risk of infection.” The FDA said this recommendation extends to patients who received injectable ophthalmic drugs made by NECC, although...
Read More

Viagra New Ad Stirs Controversy as Melanoma Concerns Grow

The United States is one of a handful of countries that allow drug makers to market directly to consumers through TV commercials. The practice should be illegal. Pfizer's new round of advertising for Viagra has is stirring new concerns over Viagra advertising practices. , social media and online news sites have been abuzz after Pfizer’s latest advertising campaign for Viagra ran with an attractive woman imploring viewers to talk to their doctor about erectile dysfunction and Viagra. The Forbes article focused on the idea that such ads are generating backlash because they are perceived as being inappropriate. The article quoted a doctor who works for Pfizer as saying he felt uncomfortable when his 11-year-old daughter started asking him about the ads. The ads also raise concerns about marketing drugs directly to consumers because it allows drug companies to pressure doctors to prescribe their drugs by winning over their patients. Pfizer is also facing other concerns about Viagra, namely concerns that the drug can cause Viagra melanoma. Melanoma is a particularly-dangerous form of skin cancer. A recent epidemiological study found that patients taking Viagra had a higher rate of melanoma than their peers. The study also found that patients with erectile...
Read More

Vioxx Litigation

If you are seeking information about a potential Vioxx case please call us at (615) 742-1775 or toll-free at (800)-394-2119. You may also e-mail us. We are actively investigating claims on behalf of persons who took Vioxx and have suffered significant injuries. What You Should Know In 1999, Merck & Co. introduced and began marketing Vioxx (rofecoxib), which quickly became a hugely popular prescription pain reliever for the treatment of osteoarthritis, acute pain, menstrual pain and rheumatoid arthritis. Vioxx is a non-steroidal anti-inflammatory drug ("NSAID") known as a COX-2 inhibitor. By early 2000, less than a year after the drug was introduced, a study that monitored over 7,000 patients found that people who take Vioxx have five times greater risk of heart attack than those who take other painkillers. Despite the results of this trial, Merck waited another two years before warning physicians of the cardiovascular risks associated with its multi-billion-dollar-a-year drug. During that time, scores of patients suffered heart attacks and strokes while taking Vioxx. COX-2 is an enzyme made when cells are injured, which triggers pain and inflammation Merck had hoped that Vioxx would become a "blockbuster drug" to rival Pfizer Inc.'s COX-2 inhibitor Celebrex and other traditional...
Read More
Tennessee Actos Lawyer Files Suit in Federal Court

Tennessee Actos Lawyer Files Suit in Federal Court

Actos Side Effects: Diabetes drug linked to cancer and serious injuries According to a recent warning issued by the FDA the drug Actos, used to treat Type 2 diabetes, has been linked to an increased risk of bladder cancer especially in patients who have used the medication for more than year. On June 15, 2011 the Food and Drug Administration (FDA) issued a safety alert regarding pioglitazone, the active ingredient in diabetes drug Actos. Studies have indicated that the risk of bladder cancer associated with products that contain pioglitazone, such as Takeda Pharmaceutical's drug Actos, increases with long term usage. Click here for a free & confidential case review The FDA Actos warning: The U.S. Food and Drug Administration (FDA) is informing the public that use of the diabetes medication Actos (pioglitazone) for more than one year may be associated with an increased risk of bladder cancer.If you take or have taken Actos and contracted bladder cancer, contact our Tennessee Actos lawyers for a free consultation toll-free (800) 394-2119 or fill out our form. Actos (pioglitazone hydrochloride) is classified in a group of drugs called thiazolidinediones all of which are used to treat diabetes. This class of drugs has been...
Read More